These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 9770649

  • 21. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
    Darbha R, Phogat S, Labrijn AF, Shu Y, Gu Y, Andrykovitch M, Zhang MY, Pantophlet R, Martin L, Vita C, Burton DR, Dimitrov DS, Ji X.
    Biochemistry; 2004 Feb 17; 43(6):1410-7. PubMed ID: 14769016
    [Abstract] [Full Text] [Related]

  • 22. A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.
    Zvi A, Tugarinov V, Faiman GA, Horovitz A, Anglister J.
    Eur J Biochem; 2000 Feb 17; 267(3):767-79. PubMed ID: 10651813
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
    Lawoko AL, Johansson B, Hjalmarsson S, Christensson B, Ljungberg B, Al-Khalili L, Sjölund M, Pipkorn R, Fenyö EM, Blomberg J.
    J Med Virol; 1999 Oct 17; 59(2):169-79. PubMed ID: 10459152
    [Abstract] [Full Text] [Related]

  • 26. Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades.
    Zhang MY, Shu Y, Sidorov I, Dimitrov DS.
    Antiviral Res; 2004 Mar 17; 61(3):161-4. PubMed ID: 15168796
    [Abstract] [Full Text] [Related]

  • 27. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
    Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PW, Robinson J, Van Ryk D, Wang L, Burton DR, Freire E, Wyatt R, Sodroski J, Hendrickson WA, Arthos J.
    Nature; 2002 Dec 12; 420(6916):678-82. PubMed ID: 12478295
    [Abstract] [Full Text] [Related]

  • 28. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
    Stanfield RL, Gorny MK, Williams C, Zolla-Pazner S, Wilson IA.
    Structure; 2004 Feb 12; 12(2):193-204. PubMed ID: 14962380
    [Abstract] [Full Text] [Related]

  • 29. Epitope mapping antibody-antigen complexes by nuclear magnetic resonance spectroscopy.
    Kustanovich I, Zvi A.
    Methods Mol Biol; 1996 Feb 12; 66():25-37. PubMed ID: 8959701
    [No Abstract] [Full Text] [Related]

  • 30. Identification of the epitopes of calcitonin gene-related peptide (CGRP) for two anti-CGRP monoclonal antibodies by 2D NMR.
    Hubbard JA, Raleigh DP, Bonnerjea JR, Dobson CM.
    Protein Sci; 1997 Sep 12; 6(9):1945-52. PubMed ID: 9300494
    [Abstract] [Full Text] [Related]

  • 31. Crystal structure of the principal neutralization site of HIV-1.
    Ghiara JB, Stura EA, Stanfield RL, Profy AT, Wilson IA.
    Science; 1994 Apr 01; 264(5155):82-5. PubMed ID: 7511253
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody.
    Zvi A, Kustanovich I, Feigelson D, Levy R, Eisenstein M, Matsushita S, Richalet-Sécordel P, Regenmortel MH, Anglister J.
    Eur J Biochem; 1995 Apr 01; 229(1):178-87. PubMed ID: 7538073
    [Abstract] [Full Text] [Related]

  • 36. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.
    Stanfield RL, Ghiara JB, Ollmann Saphire E, Profy AT, Wilson IA.
    Virology; 2003 Oct 10; 315(1):159-73. PubMed ID: 14592768
    [Abstract] [Full Text] [Related]

  • 37. Presentation of HIV V3 loop epitopes for enhanced antigenicity, immunogenicity and diagnostic potential.
    Fontenot JD, VanCott TC, Parekh BS, Pau CP, George JR, Birx DL, Zolla-Pazner S, Gorny MK, Gatewood JM.
    AIDS; 1995 Oct 10; 9(10):1121-9. PubMed ID: 8519447
    [Abstract] [Full Text] [Related]

  • 38. Polyclonal antiidiotypic antibodies mimicking gp120 of HIV-1.
    Sperlagh M, Hoxie J, Maruyama H, Stefano K, Gonzales-Scarano F, Prewett M, Liang S, Matsushita S, Herlyn D.
    Viral Immunol; 1994 Oct 10; 7(2):61-9. PubMed ID: 7531443
    [Abstract] [Full Text] [Related]

  • 39. AIDS research. Novel antibody response may explain HIV vaccine success.
    Cohen J.
    Science; 2011 Sep 16; 333(6049):1560. PubMed ID: 21921167
    [No Abstract] [Full Text] [Related]

  • 40. [Conformational analysis of major antigenic determinant of HIV-1 gp120 protein using the NMR spectroscopy data].
    Andrianov AM.
    Mol Biol (Mosk); 1996 Sep 16; 30(5):1173-83. PubMed ID: 8992304
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.